Health Care • Hospital/Nursing Management
$181.52 ▼ -4.80
(-2.58%)
MKT CAP: $10.87B • VOL: 411.7K
52W L $142 52W H $218
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$152
MEDIAN
$203
MEAN
$207
HIGH
$247
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ENSG TAPE
ENSG // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $219.64 | $208.75 | 2025-02-14 | $165.18 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $228.72 | $214.19 | 2025-02-06 | $170.63 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $206.93 | $199.67 | 2025-01-29 | $174.26 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $185.15 | — | 2025-01-17 | $177.89 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $159.74 | $172.44 | 2025-01-09 | $161.55 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $216.01 | $188.78 | 2024-12-18 | $157.92 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $176.07 | $183.34 | 2024-12-04 | $168.81 | -4.3% | 48% | C |